HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karen M Braas Selected Research

Abnormal Reflex (Hyperreflexia)

11/2010PACAP/VIP and receptor characterization in micturition pathways in mice with overexpression of NGF in urothelium.
11/2008Urinary bladder function and somatic sensitivity in vasoactive intestinal polypeptide (VIP)-/- mice.
11/2008PACAP-mediated ATP release from rat urothelium and regulation of PACAP/VIP and receptor mRNA in micturition pathways after cyclophosphamide (CYP)-induced cystitis.
7/2006A role for pituitary adenylate cyclase activating polypeptide (PACAP) in detrusor hyperreflexia after spinal cord injury (SCI).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Karen M Braas Research Topics

Disease

4Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2019 - 02/2011
4Inflammation (Inflammations)
11/2010 - 04/2006
4Abnormal Reflex (Hyperreflexia)
11/2010 - 07/2006
4Cystitis
11/2008 - 04/2006
3Pain (Aches)
01/2021 - 11/2014
3Chronic Pain
01/2019 - 11/2014
3Hypersensitivity (Allergy)
01/2017 - 11/2010
2Migraine Disorders (Migraine)
01/2019 - 11/2012
2Weight Loss (Weight Reduction)
11/2014 - 06/2014
2Mental Disorders (Mental Disorder)
11/2014 - 06/2014
2Weight Gain
09/2014 - 06/2014
1Infections
01/2021
1Metabolic Diseases (Metabolic Disease)
01/2019
1Neuralgia (Stump Neuralgia)
01/2017
1Anxiety Disorders (Anxiety Disorder)
11/2014
1Body Weight (Weight, Body)
06/2014
1Anorexia
06/2014
1Central Nervous System Diseases (CNS Diseases)
11/2008
1Pheochromocytoma
09/2007
1Peripheral Nerve Injuries
09/2007
1Spinal Cord Injuries (Spinal Cord Injury)
07/2006
1Interstitial Cystitis (Interstitial Cystitis, Chronic)
07/2006

Drug/Important Bio-Agent (IBA)

15Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
01/2021 - 04/2006
5Type I Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA
01/2017 - 11/2008
4Peptides (Polypeptides)IBA
11/2014 - 09/2007
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2008 - 04/2006
3Adenylyl Cyclases (Adenylyl Cyclase)IBA
11/2014 - 11/2008
2Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA
06/2014 - 11/2008
2CytokinesIBA
11/2008 - 11/2008
2Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
11/2008 - 11/2008
1GlucocorticoidsIBA
01/2021
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2017
1Biomarkers (Surrogate Marker)IBA
02/2011
1Proteins (Proteins, Gene)FDA Link
11/2010
1Neuropeptide Receptors (Neuropeptide Receptor)IBA
11/2010
1Nerve Growth Factor (NGF)IBA
11/2010
1Adenosine Triphosphate (ATP)IBA
11/2008
1Messenger RNA (mRNA)IBA
11/2008
1Nerve Growth Factors (Neurotrophins)IBA
11/2008

Therapy/Procedure

1Transplantation
11/2008
1Intravesical Administration
04/2006